AβPP-selective BACE inhibitors (ASBI): novel class of therapeutic agents for Alzheimerʼs disease - Descamps, O; Spilman, P; Zhang, Q; Libeu, C P; Poksay, K; Gorostiza, O; Campagna, J; Jagodzinska, B; Bredesen, D E; John, V (J Alzheimers Dis, 2013)